showing 2208 abstracts

results from 'European Society for Medical Oncology' where authors matches anything

Details title year
Details 114P Molecular imaging with 18F-fluoroestradiol (18F-FES) to assess intra- ... 2017
Details 383P A phase I dose-escalation study of the novel peptide ALM201 in patient... 2017
Details 652P Iron deficiency anemia in gastric cancer: A Canadian single site retro... 2017
Details 916P Biological assessment of viable germ cell tumor (VT) in patients (pts)... 2017
Details 1186P Phase Ia study of a humanized anti-PD-1 monoclonal antibody (JS001) i... 2017
Details 1477PD Prognosis of desmoid tumours initially managed with surveillance onl... 2017
Details 115P Evaluation of a predictive radiomics signature for response to immune ... 2017
Details 385P Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the fi... 2017
Details 653P Is surgical resection beneficial in recurrent or metastatic gastric ca... 2017
Details 917P A single centre retrospective review of testosterone deficiency in ger... 2017
Details 1187P A Phase 1/2 trial of intratumoral (i.t.) IMO-2125 (IMO) in combinatio... 2017
Details 1478PD Adult Translocation-related soft tissue sarcomas (TRS): Presentation... 2017
Details 116P Clinical and pre-clinical biomarkers of Regorafenib (REG) efficacy in ... 2017
Details 386P Efficacy of pembrolizumab in phase 2 KEYNOTE-164 and KEYNOTE-158 studi... 2017
Details 654P Nomograms for pre- and post- operative prediction of long-term surviva... 2017
Details 918TiP Pembrolizumab and nanoparticle albumin bound paclitaxel (nab- paclit... 2017
Details 1188P Clinical and immune effects patients with progressive disease treated... 2017
Details 1479PD Phase II study of TAS-116, an oral inhibitor of heat shock protein 9... 2017
Details 117P Anti-HER2 therapy efficacy in HER2-negative metastatic breast cancer w... 2017
Details 387P Preliminary results from subsets of patients (pts) with advanced gastr... 2017
Details 655P Safety of neoadjuvant/adjuvant chemotherapy for gastroesophageal cance... 2017
Details chemotherapy versus chemotherapy in advanced urothelial cancer: Phase 3 KE... 2017
Details 1189P 4SC-202 plus anti-PD1: Breaking PD1-refractoriness to increase effica... 2017
Details soft tissue sarcoma: Interim analysis of immunogenicity, tumor control and... 2017
Details 118P Nationwide external quality assessment (EQA) of EGFR testing in circul... 2017
Details 388P Preliminary results from a subset of patients (pts) with advanced head... 2017
Details 656P Peritoneal lavage CEA mRNA levels predict conversion gastrectomy outco... 2017
Details 920TiP Afatinib in patients with advanced or metastatic urothelial carcinom... 2017
Details 1192P Cytomegalovirus reactivation in patients with refractory checkpoint i... 2017
Details 1481PD Efficacy and safety of palbociclib in patients with advanced gastroi... 2017
Details 2 antisense (trabedersen) therapy: Results of a phase II trial... 2017
Details 389P Preliminary results from a subset of patients (pts) with advanced ovar... 2017
Details 657P Nutritional recovery after open and laparoscopic distal gastrectomy fo... 2017
Details 921TiP A Phase III, randomized, double-blind, multicenter study of adjuvant... 2017
Details cancer patients... 2017
Details 1482PD Notch pathway inhibition with LY3039478 in soft tissue sarcoma (STS)... 2017
Details 120P Predictive assay for anti-angiogenic agents (AADx) identifies molecula... 2017
Details 390P A phase I study of durvalumab (D) in combination with olaparib (O) and... 2017
Details 658P Randomized, controlled Phase III trial comparing 3D and 2D laparoscopi... 2017
Details 922TiP KEYNOTE-564: Phase 3 trial of pembrolizumab in the adjuvant treatmen... 2017
Details 1194P Impact of prior immune checkpoint inhibitors on haematological toxici... 2017
Details 1483PD Imatinib in combination with everolimus in patients with progressive... 2017
Details 121P Influence of HIF-2alpha deregulation and overexpression of VEGF ligand... 2017
Details 391P Phase I expansion of olaparib (PARP inhibitor) and AZD5363 (AKT inhibi... 2017
Details 659P Anthracycline-based triplets do not improve the efficacy of platinum- ... 2017
Details 923TiP A phase 2 BIOmarker driven trial with Nivolumab and Ipilimumab or VE... 2017
Details 1195P Compromised efficacy of PD-L1 blockade therapy in axenic (germ- free)... 2017
Details 1484PD A matching-adjusted indirect comparison of trabectedin and pazopanib... 2017
Details 122P Cell-free (cf)DNA analysis identifies PIK3CA/AKT1 mutations associat... 2017
Details 392P Generation of a novel preclinical PK/PD model provides insights into P... 2017
Details 660P First-in-human study of IMAB362, an anti-claudin 18.2 monoclonal antib... 2017
Details 924TiP Savolitinib versus sunitinib in patients with MET-driven, unresectab... 2017
Details 1197P iRGD enhances T cells infiltration and augments response to PD-1 gene... 2017
Details 1485P Localized undifferentiated endometrial sarcomas (LUES): Results of a ... 2017
Details 123P Genotyping circulating tumor DNA identifies metastatic colorectal canc... 2017
Details 393P Pharmacodynamic (PD) biomarkers for the p70S6K/Akt inhibitor, M2698: T... 2017
Details 661P Bidirectional chemotherapy in gastric cancer (GC) with peritoneal carc... 2017
Details -selective inhibitor TAK-117 vs everolimus in adults with advanced or metas... 2017
Details 1198P Immunomodulation by regorafenib alone and in combination with anti PD... 2017
Details 1486P An epidemiological insight into epithelioid sarcoma (ES): The open is... 2017
Details 124P Role of circulating miRNAs as prognostic biomarkers in resected early-... 2017
Details 394P Phase 1 study of ipatasertib (AKT inhibitor) for investigating safety,... 2017
Details 662P Gastrectomy after response to intraperitoneal and systemic chemotherap... 2017
Details 926TiP Phase Ib/II trial of interleukin-2 (IL-2) and nivolumab in metastati... 2017
Details 1199P Effect of MEK inhibition on PD-L1 and MCH-1 expression and on cytokin... 2017
Details 1487P Natural history of alveolar soft part sarcoma (ASPS): Impact of brain... 2017
Details 125P Targeted methylation sequencing of plasma cell-free DNA identifies pat... 2017
Details 395P DS-1205b, a novel, selective, small-molecule inhibitor of AXL, delays ... 2017
Details 663P Change in the molecular profile of tumor tissues during treatment with... 2017
Details 927TiP Cabozantinib in patients with advanced penile squamous cell carcinom... 2017
Details 1200P Exploring personalized immunotherapy opportunities in colorectal canc... 2017
Details 1488P Treatment patterns, clinical outcomes and prognostic factors of visce... 2017
Details 126P Single-cell combined mutation and gene expression studies of circulati... 2017
Details 397P Immune related adverse events (irAEs) in early phase immunotherapy (IO... 2017
Details 664P Phase 1 Study of IMAB362 with immunomodulation in patients with advanc... 2017
Details 930O Quality of life in patients with recurrent ovarian cancer (OC) treated... 2017
Details 1203P Functional screening of B7H6-based chimeric antigen receptor (CAR) de... 2017
Details 1489P High dose loco-regional chemotherapy for locally advanced angiosarcom... 2017
Details 127P EGFR copy number aberrations detected in cfDNA from advanced NSCLC pat... 2017
Details 398P Drug-induced electrolyte abnormalities in oncology phase I trials: Ana... 2017
Details 665P Modified Glasgow prognostic score, prognostic nutritional index and EC... 2017
Details R -TF-ADC) in patients with relapsed, recurrent and/or metastatic cervical... 2017
Details 1204P Concurrent immuno-radiotherapy in lung and renal cancer- a new treatm... 2017
Details 1490P Primary cardiac sarcoma (PCS): A multi-national retrospective review ... 2017
Details 128P Detection of esophageal cancer patients using circulating serum microR... 2017
Details 400P LCZ 696, administered during doxorubicin, trastuzumab or pertuzumab tr... 2017
Details 666P Accuracy and prognostic significance of oncologists estimates and scen... 2017
Details 932PD Efficacy of olaparib maintenance therapy in patients (pts) with plati... 2017
Details 1205P Optimum fractionation of radiation dose to combine anti-PD-1 mAb in M... 2017
Details 1491P Primary cardiac sarcoma: A retrospective study in two Korean tertiary... 2017
Details 129P First prospective multicenter real-world RAS mutation comparison betwe... 2017
Details 401P MEK inhibitor retinopathy... 2017
Details 667P ERBB3 mutations in advanced gastric signet-ring cell carcinoma (SRCC) ... 2017
Details 933PD The exposure-response relationship of niraparib in patients with gBRC... 2017
Details 1206P Efficacy of tumor treating fields (TTFields) and anti-PD-1 in non-sma... 2017
Details 1492P The differences in recurrence and survival of extremity liposarcoma s... 2017
Details 130P EGFR plasma testing in routine practice by real-time PCR in lung cance... 2017
Details 402P A Phase I/II study everolimus in combination with paclitaxel- carbopla... 2017
Details 668P Estimating 12-weeks life expectancy in metastatic gastric cancer (mGC)... 2017
Details 934PD Safety and Efficacy of Niraparib in Elderly Patients (Pts) with Recur... 2017
Details Adjuvant with Nivolumab in Patients with Melanoma, Non-Small Cell Lung Car... 2017
Details 1493P The sarcoma policy checklist: Focusing policy efforts on sarcoma... 2017
Details 131P Circulating tumor cells as liquid biopsy for castration resistant pros... 2017
Details 403P Phase I studies of the novel carcinoembryonic antigen T-cell bispecifi... 2017
Details 669P TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mut... 2017
Details 935PD BRCA1&2 tumoral and germline status for ovarian cancer patients in fi... 2017
Details 1208TiP A phase II exploratory study of durvalumab (MEDI4736) in HIV-1 pati... 2017
Details 1494P Dermatofibrosarcoma protuberans might not benefit from postoperative ... 2017
Details 132P Biomarker analysis using circulating tumor DNA in patients treated wit... 2017
Details 404P Dose escalation study of vemurafenib with crizotinib or sorafenib in p... 2017
Details 672P A multicentre, phase II study with cabazitaxel in previously treated p... 2017
Details 936PD Actionable molecular alterations in advanced gynecologic malignancies... 2017
Details agonist LYC-55716 in treating locally advanced or metastatic solid tumors... 2017
Details 1495P Low-dose chemotherapy with methotrexate and vinblastine for desmoid t... 2017
Details 133P Heparinase enables reliable quantification of circulating tumor DNA fr... 2017
Details 405P Hepatic functional imaging and genomics to predict irinotecan pharmaco... 2017
Details 673P Comparison of cytotoxic backbones for first line trastuzumab- containi... 2017
Details 937PD PD-L1 expression and prognosis significance in advanced ovarian cance... 2017
Details 1210TiP A phase I global trial targeting multiple solid and hematologic mal... 2017
Details 1496P EORTC experience with advanced/metastatic epithelioid sarcoma patient... 2017
Details 134P Circulating tumour DNA (ctDNA) in the clinical management of patients ... 2017
Details 406P Ongoing phase 1 trial of SL-801, a novel XPO-1 inhibitor, in patients ... 2017
Details 674P Nivolumab (NIVO) in patients (pts) with advanced (adv) chemotherapy- r... 2017
Details 938PD Prognostic relevance of immune-related gene expression signatures (ir... 2017
Details 1211TiP FAK-PD1: a phase I/IIa trial of FAK (defactinib) & PD-1 (pembrolizu... 2017
Details 1497P Efficacy and safety of patients treated long-term with trabectedin (t... 2017
Details 135P Genome-wide methylation analysis reveals a prognostic classifier for n... 2017
Details 407P Antitumor efficacy of triple monoclonal antibody inhibition of epiderm... 2017
Details 675P Involvement of the immunoregulator MZB1 in progression of gastric canc... 2017
Details 939PD An increased ratio of cytotoxic to suppressive T cells after neoadjuv... 2017
Details 1212TiP PIVOT-02: A phase 1/2, open-label, multicenter, dose escalation and... 2017
Details 65 years) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) from the ... 2017
Details 136P Epigenetic biomarkers in breast cancer: Preliminary results from H3K27... 2017
Details 408P Validation of the Royal Marsden Hospital (RMH) prognostic score on an ... 2017
Details 676P PD-L1 immunohistochemistry (IHC) by three different assays and molecul... 2017
Details 940PD Long term quality of life among epithelial ovarian cancer patients: T... 2017
Details 1213O Characterization of complete responses (CRs) in patients with advance... 2017
Details 1499P The routine real-life use of trabectedin (T) in patients with advance... 2017
Details 137P Bioinformatic estimate of biomarker-positive populations in genomics- ... 2017
Details 409P Updated results of phase 1 study of DS-8201a in patients with HER2 exp... 2017
Details 677P Treatment of advanced gastric cancer based on Laurens histological: Re... 2017
Details 942PD Vanucizumab (VAN) in combination with atezolizumab (ATEZO) for platin... 2017
Details 1214O Epacadostat plus pembrolizumab in patients with advanced melanoma: Ph... 2017
Details 1501P Safety and efficacy of pazopanib (PAZ) in advanced soft tissue carcin... 2017
Details 138P Detection of microsatellite instability (MSI) in colorectal cancer sam... 2017
Details 410P Phase I study of the investigational, oral pan-RAF kinase inhibitor TA... 2017
Details 678P Comparison of oxaliplatin-related spleen enlargement in patient with g... 2017
Details 943P Location of mutation in BRCA2 gene and survival in patients with ovari... 2017
Details 1215O Results of COLUMBUS Part 2: A phase 3 trial of encorafenib (ENCO) plu... 2017
Details 1502P Evolution in neutrophil-to-lymphocyte ratio (NLR) among advanced soft... 2017
Details 139P Gene expression BIRC5, Erb-b2/Her2-neu, ESR1, PGR1, MMP11, MDR1, MRP1,... 2017
Details 411P Pharmacological activity of CB-103: An oral pan-NOTCH inhibitor with a... 2017
Details 679P Safety and efficacy of S-1 treatment in elderly patients with advanced... 2017
Details 944P POLE mutations and MSI were positive predictive factors for progressio... 2017
Details 1216O KEYNOTE-022 update: phase 1 study of first-line pembrolizumab (pembro... 2017
Details 1503P Benefit of the use of tyrosine kinase inhibitors (TKIs) in patients (... 2017
Details 140P Metabolic syndrome and inflammation in castration resistant prostate c... 2017
Details 412P Design and development of potent E1 ubiquitin activating enzyme inhibi... 2017
Details 680P Phase II study of modified docetaxel, cisplatin and S-1 (mDCS) combina... 2017
Details 945P Evaluation of circulating tumor DNA in patients with ovarian cancer ha... 2017
Details 1217PD Comprehensive genomic profiling (CGP) and tumor mutational burden (T... 2017
Details 1504P Response to apatinib in advanced alveolar soft part sarcoma... 2017
Details 141P Ischemic stroke and cancer correlation: A stroke unit experience... 2017
Details 413P RX-3117, a novel hypomethylating agent, shows promising therapeutic ac... 2017
Details 681P Clinical impact of programmed death ligand-1 and -2 expression after p... 2017
Details 946P Predictive and prognostic value of tumor cells and circulating plasma ... 2017
Details 1218PD Precision medicine for the treatment of metastatic uveal melanoma: A... 2017
Details 1505P Analysis of expression of immunomodulation factors in alveolar soft- ... 2017
Details 142P longitudinal exploratory analysis of prior- surgery everolimus circula... 2017
Details 414P A phase Ib trial of JX-594 (Pexa-Vec), a targeted multimechanistic onc... 2017
Details 682P Clinical practice observation of trastuzumab (TRA) in patients (pts) w... 2017
Details 947P Circulating tumor cells as prognostic marker in ovarian carcinoma: Res... 2017
Details 1219PD Combined radiofrequency ablation and ipilimumab in uveal melanoma: R... 2017
Details 1506P PD-L1 inhibition a new therapeutic opportunity in cutaneous angiosar... 2017
Details 143P A comparison of treatment recommendations by molecular tumor boards wo... 2017
Details 415P Population pharmacokinetic analysis of OT-101 (trabedersen) in patient... 2017
Details 683P Intratumoral PD-L1 expression is associated with worse survival of pat... 2017
Details T cell spatial distribution and function in ovarian cancer... 2017
Details T) for resectable stage IIIB/C BRAF V600 mutant melanoma... 2017
Details 1507P Pembrolizumab (PEM) in patients with advanced/metastatic bone sarcoma... 2017
Details 144P Identification of germline mutation using 30-gene sequencing and clini... 2017
Details 417TiP A phase 1 study of oral LOXO 292 in adult patients with advanced sol... 2017
Details 684P Targeting c-met and DNA double-strand break (DSB) repair pathways for ... 2017
Details 948P Genomic instability is associated with increased immune infiltration a... 2017
Details NIVO) in palpable stage 3 melanoma updated relapse free survival (RFS) dat... 2017
Details 1509P Characteristics and prognosis of gastrointestinal stromal tumor in th... 2017
Details 145P Selecting patients with metastatic colorectal cancer for treatment wit... 2017
Details 418TiP Phase 1/2 study of the selective TRK inhibitor larotrectinib, in ped... 2017
Details 685P Clinical efficacy observation for endostar combined with chemotherapy ... 2017
Details 949P Tumor microenvironment in high serous ovary cancer: Characterization o... 2017
Details 1222PD Regional differences in overall survival (OS) in patients with advan... 2017
Details 1510P Early response evaluation by 18F-FDG-PET influences management in gas... 2017
Details 146P Predicting response to chemotherapy in gastric cancer patients randomi... 2017
Details 419TiP Chemosensitization of carboplatin by NOX66: Pharmacokinetics and saf... 2017
Details 686P Modified epirubicin and oxaliplatin plus capecitabine (EOX) Regimen as... 2017
Details 950P Gene mutational analyses in 154 ovarian cancer (OC) samples from the R... 2017
Details IPI) or NIVO alone vs IPI among treatment-na ve patients (pts) with advance... 2017
Details 1511P Surgery in the treatment of metastatic and recurrent Gastrointestinal... 2017
Details 147P The nationwide cancer genome screening project in Japan SCRUM- Japan G... 2017
Details 420TiP Phase 1b/2 study to assess the safety, tolerability, and clinical ac... 2017
Details 687P Phase II clinical trial of second-line weekly paclitaxel plus trastuzu... 2017
Details 951P A retrospective study of endocrine therapy in high grade serous ovaria... 2017
Details 1224PD Analysis of response and survival in patients (pts) with ipilimumab ... 2017
Details 5 years) to frontline imatinib (IM): A case-control study from GEIS... 2017
Details /HER2-) early breast cancer (EBC): Results from the GEICAM/2006-10 study... 2017
Details 421TiP Phase 1b/2 study to assess the clinical effects of BGB-290 in combin... 2017
Details 688P Beyond first line treatment for advanced esophagogastric adenocarcinom... 2017
Details 952P Randomised prospective study of maintenance tamoxifen versus post adju... 2017
Details 1225PD Prognostic impact of early complete metabolic response on FDG- PET, ... 2017
Details 1513P Tumor growth rate analysis of progression-free survival (PFS) and ove... 2017
Details breast cancer (BC): 5-year analysis of the phase III ExteNET trial... 2017
Details 422TiP PROCLAIM-CX-2009: A first-in-human trial to evaluate CX-2009 in adul... 2017
Details 689P Phase I dose escalation study with expansion cohort of the addition of... 2017
Details 953P A phase 1 study to evaluate the safety and tolerability of bevacizumab... 2017
Details 1226PD Five-year efficacy and safety update from METRIC: Trametinib vs chem... 2017
Details 1514P Serum miRNA abundances discriminate imatinib-naive patients with adva... 2017
Details 151PD Efficacy and safety of biosimilar ABP 980 compared with trastuzumab i... 2017
Details 423TiP The first-in-human, dose-finding PROCLAIM-CX-072 trial to assess the... 2017
Details 690P KRAS status and HER2 targeted treatment in advanced gastric cancer... 2017
Details 955P A landmark analysis of overall survival in PR-OC patients treated with... 2017
Details 1227P Avelumab treatment in chemotherapy-na ve patients with distant metast... 2017
Details 1515P LncRNA H19, HOTAIR and MALAT1 as prognostic molecular biomarkers in G... 2017
Details 152PD Double-blind, randomized phase III study to compare the efficacy and ... 2017
Details 424TiP Phase 1b multi-indication study of the antibody drug conjugate anetu... 2017
Details 691P Inter-patient and intra-tumoral heterogeneity of oncogenic copy number... 2017
Details bevacizumab (BEV) for primary advanced ovarian cancer (OC)... 2017
Details 1228P Long-term effects of sonidegib on tumor burden: 30-month results from... 2017
Details 1516P Predictive factors of response to Sunitinib in metastatic Gastrointes... 2017
Details 153PD One-year safety, immunogenicity, and survival results from a phase II... 2017
Details 425TiP A phase 1 study of SY-1365, a selective CDK7 inhibitor, in adult pat... 2017
Details 692P Identification of an RNF43 mutated gastric cancer patient population w... 2017
Details 957P Feasibility and effectiveness of multiple lines of bevacizumab-based t... 2017
Details 1230P Modulation of Risk and Prognosis of Cutaneous Melanoma Patients by Ge... 2017
Details 1517P Analysis of PD-L1 Expression in Patients with Gastrointestinal Stroma... 2017
Details ) breast cancer... 2017
Details 426TiP First-in-human study of AMC303 as monotherapy in patients with advan... 2017
Details 693P Prognostic effect of surgery of metastases in patients with advanced g... 2017
Details 958P Impact of body mass index (BMI) on outcome in 785 patients (pts) recei... 2017
Details 1231P Role of an intronic polymorphism in the CREB1 gene, involved in melan... 2017
Details 1518P Gastrointestinal stromal tumors secrete Ghrelin and express ghrelin r... 2017
Details ) early breast cancer treated with neoadjuvant lapatinib and trastuzumab wi... 2017
Details 427O Pembrolizumab for patients with PD-L1positive advanced carcinoid or pa... 2017
Details 694P Comparison of HER2 related molecular expression and its significance f... 2017
Details HIPEC in advanced epithelian ovarian malignancy -100 consecutive cases -IN... 2017
Details 1232P Investigation of AMBRA1 as a melanoma susceptibility gene... 2017
Details 1519P Primary pleomorphic sarcoma (PS) and leiomyosarcoma (LMS) of bone: Re... 2017
Details 156PD Targeted NGS profiling identifies genomic alterations associated with... 2017
Details 428O Immune landscape of pancreatic neuroendocrine tumours (PanNETs)... 2017
Details 695P Real world data about clinical efficacy and safety of apatinib in the ... 2017
Details 960P Role of laparotomy-based parameters in assessment of optimal primary d... 2017
Details 1233P Influence of an intronic polymorphism in the MITF gene, of melanogeni... 2017
Details 1520P Development of a new promising rescue agent for high dose methotrexat... 2017
Details 157PD 10 years follow up of the RASTER study; implementing a genomic signat... 2017
Details 429O A phase II trial of palbociclib in metastatic grade 1/2 pancreatic neu... 2017
Details 696P Correlation between SPARC expression and efficacy of nab-paclitaxel fo... 2017
Details 961P ICON7: Ovarian cancer, platinum second-line chemotherapy and overall s... 2017
Details 1234P Hybrid-capture based genomic profiling identifies BRAF V600 and non-V... 2017
Details 1521P Role of intraarterial cisplatin and intravenous adriamycin as neoadju... 2017
Details ) early breast cancer (EBC): Analysis from the ALTTO trial (BIG 2-06)... 2017
Details 430O Different RNA expression profile defines prognosis in grade 1/2 neuroe... 2017
Details 697P Detection of microsatellite instability (MSI) with a novel panel of bi... 2017
Details 962P Disease burden during the watchful waiting period in patients with rec... 2017
Details 1235P Post-transcriptional regulation of immune checkpoint genes by mir- 16... 2017
Details 1522P Biomarkers of malignant cell growth used to assess the risk of osteos... 2017
Details 159PD Neoadjuvant therapy with trastuzumab emtansine and pertuzumab in pati... 2017
Details 431O Genomic subtypes of pulmonary large cell neuroendocrine carcinoma (LCN... 2017
Details 698P A dose-response study of ramucirumab treatment in patients with gastri... 2017
Details 963P Impact of chemotherapy (CT) in heavily pretreated BRCA1/2 mutation car... 2017
Details 1236P Does melanoma or other skin cancers belong to the BRCA2 phenotype?... 2017
Details 1523P Efficacy of second line treatment with etoposide and ifosfamide in ad... 2017
Details 160PD Statistical model to predict brain metastasis risk in patients with e... 2017
Details 432PD Prognostic impact of RNA expression profile (EP) in the phase III DEC... 2017
Details 699P The effectiveness of the 8th American Joint Committee on Cancer TNM cl... 2017
Details 964P Modeling and impact of organ function on the population pharmacokineti... 2017
Details 1237P Resected malignant melanoma at high risk of recurrence in SEER- Medic... 2017
Details 1524P AG-120, a novel IDH1 targeted molecule, inhibits invasion and migrati... 2017
Details 161PD Surrogate endpoints for overall survival in randomized controlled tri... 2017
Details 433PD Comprehensive genomic profiling of metastatic and relapsed thyroid gl... 2017
Details 700P Comparison of prognostic models for hepatocellular carcinoma (HCC) in ... 2017
Details 965P Evaluation of tumour responses and olaparib efficacy in platinum- sens... 2017
Details 1238P Independent prognostic impact of lympho-vascular invasion in cutaneou... 2017
Details 1525TiP Geriatric assessment of elderly chemotherapy-na ve patients treated... 2017
Details 162PD Pathological response in a triple-negative breast cancer cohort treat... 2017
Details 434PD Impact of duration of dose interruption on the efficacy of lenvatinib... 2017
Details 701P Final data from a phase Ib trial of tepotinib in Asian patients with a... 2017
Details 966P Outcomes of the combination trabectedin and pegylated liposomal doxoru... 2017
Details 1239P Validating prognostic models in metastatic uveal melanoma (MUM), an i... 2017
Details 1526TiP CDK4/6 inhibition in locally advanced/metastatic chordoma (NCT PMO-... 2017
Details 163PD Long-term survival analysis of the randomized phase II trial investig... 2017
Details 436PD Preliminary safety and efficacy of rovalpituzumab tesirine in patient... 2017
Details 702P Correlation between overall survival (OS) and time to progression (TTP... 2017
Details 967P An observational, multicenter, prospective study of trabectedin plus p... 2017
Details 1240P Impact of an active surveillance programme on outcome of patients (pt... 2017
Details 1527O Top-line data from the randomized phase 2 IMPULSE study in small- cel... 2017
Details 164P Impact of lack of surgery on outcomes in elderly patients with non- me... 2017
Details 437PD Integrative DNA methylome and miRNA transcriptome analysis for new bi... 2017
Details 703P Cost effectiveness of selective internal radiation therapy (SIRT) with... 2017
Details 968P PRO-002, a phase Ib dose-escalation study of NUC-1031 with carboplatin... 2017
Details V): a pooled analysis... 2017
Details 1528PD Initial results of BMS-986012, a first-in-class fucosyl-GM1 mAb, in ... 2017
Details 166P Eight-year follow up results of the OTOASOR trial: The optimal treatme... 2017
Details 438PD Improved time to quality of life deterioration in patients with progr... 2017
Details 704P Ang-2 polymorphisms in relation to outcome in advanced HCC patients re... 2017
Details 969P Phase 1/2 trials of peptides cocktail vaccine for resistant cervical a... 2017
Details 1242P Neutrophil to Lymphocyte Ratio (NLR) as an independent prognostic mea... 2017
Details 1529PD Activity of lurbinectedin as single agent and in combination in pati... 2017
Details 167P Time to surgery in early breast cancer treated with neoadjuvant chemot... 2017
Details 439PD Peptide receptor radionuclide therapy of neuroendocrine neoplasms usi... 2017
Details 705P Circulating miRNA biomarkers predicting regorafenib (REG) clinical ben... 2017
Details 970P A phase 1 study of selinexor (S) in combination with paclitaxel (P) an... 2017
Details 1243P The prognostic significance of distant metastasis free interval (DMFI... 2017
Details 1530PD Results of a randomized, placebo-controlled, phase 2 study of tarex-... 2017
Details 168P Updated results of the Breast cancer task force phase II study of neoa... 2017
Details 440PD Efficacy and safety of telotristat ethyl in patients with carcinoid s... 2017
Details 706P Overall survival (OS) by platelet count at baseline in patients with h... 2017
Details 971P Pazopanib and oral cyclophosphamide in women with platinum resistant e... 2017
Details 1244P Hospitalization Rates in COLUMBUS Part 1: A Phase 3 Trial of Encorafe... 2017
Details 1531PD Clinical outcomes for EGFR-mutant adenocarcinomas (AC) that transfor... 2017
Details 169P Neoadjuvant eribulin following anthracycline and taxane in triple nega... 2017
Details 441PD Follow-up recommendations for completely resected gastroenteropancrea... 2017
Details 707P Network meta-analysis (NMA) of treatments for unresectable hepatocellu... 2017
Details 972P Apatinib as a salvage treatment in gynecologic cancer patients failed ... 2017
Details 1245P Quality-of-life (QoL) in COLUMBUS part 1: A phase 3 trial of encorafe... 2017
Details 1532P The role of thoracic radiotherapy on peripheral lymphocyte subsets in... 2017
Details 170P Impact of neoadjuvant therapy (NT) and pathological complete response ... 2017
Details 442P Long-term survival of patients with carcinoid syndrome in clinical tri... 2017
Details 708P Epidemiological study of histologically proven advanced hepatocholangi... 2017
Details 973P A GINECO phase II study of Navitoclax (ABT 263) in women with platinum... 2017
Details 1246P Loss of USP28 drives resistance to BRAF targeted therapy in melanoma... 2017
Details 1534P Antidepressants simulate enriched environment enhance platinum chemos... 2017
Details 171P Composite index of risk shows that benefit from adjuvant dose dense ch... 2017
Details 443P Identifying symptom and quality of life improvements in patients with ... 2017
Details 709P A Phase II study of sorafenib and yttrium-90 glass microspheres for ad... 2017
Details 974P Reproductive function in patients (pts) with malignant ovarian germ ce... 2017
Details 1247P Patterns of progression in metastatic melanoma patients treated with ... 2017
Details 1535TiP KEYNOTE-604: Phase 3 trial of pembrolizumab plus etoposide/ platinu... 2017
Details 172P The prognostic impact of chemotherapy induced amenorrhea in women trea... 2017
Details 444P Carcinoid syndrome: Patient outcomes from a European Neuroendocrine Tu... 2017
Details 710P Assessing cancer risk in patients with HFE gene variants and type 1 he... 2017
Details 975P Preoperative MRI versus intra-operative frozen section in surgical man... 2017
Details 1248P Tumor-stroma interactions as a determinant of drug resistance in BRAF... 2017
Details 1536TiP An open-label study on safety and tolerability of rovalpituzumab te... 2017
Details 173P Determinants and outcomes associated with delays in adjuvant chemother... 2017
Details 445P Relationship between symptoms and health-related quality of life benef... 2017
Details 711P Selective Internal Radiation Therapy (SIRT) with Yttrium-90-glass- mic... 2017
Details 976P Impact of the adjuvant management and risk factors on survival in FIGO... 2017
Details 1249P Extended survival analysis of ipilimumab for the treatment of advance... 2017
Details 1537TiP A phase 3 trial of rovalpituzumab tesirine vs topotecan in patients... 2017
Details 174P Adjuvant chemotherapy in pT1ab node-negative triple negative breast ca... 2017
Details 446P Benefit of oral monotherapy with pazopanib in metastatic gastroenterop... 2017
Details 712P Effect of adjuvant chemotherapy and chemoradiotherapy in patients with... 2017
Details 977P Is chemotherapy worthwhile in patients with FIGO stage 1B, lymph nodes... 2017
Details 1250P Real-world use of ipilimumab and nivolumab monotherapy or in combinat... 2017
Details ipilimumab in small cell lung cancer... 2017
Details 3700 patients with her2-positive early breast cancer treated with trastuzu... 2017
Details 447P High hepatic tumor burden and cardiovascular comorbidities linked to c... 2017
Details 713P The mutational landscape of periampullary adenocarcinomas in relation ... 2017
Details 978P Significance of MSH2 promoter methylation in endometrial cancer with M... 2017
Details 1251P Baseline neutrophil-to-lymphocyte ratio and its values monitored over... 2017
Details 1539O Pre-chemotherapy nutritional status and chemotherapy response: An obs... 2017
Details 176P Clinical outcomes of delayed start of trastuzumab treatment in patient... 2017
Details 448P Bone metastases in patients with neuroendocrine neoplasms: A survey of... 2017
Details 714P Gemcitabine and platinum- based chemotherapy in first line treatment o... 2017
Details 979P Achievement of complete response (CR) in metastatic or recurrent cervi... 2017
Details pembrolizumab (pembro) for recurrent or metastatic squamous cell carcinoma... 2017
Details 1540O Fosaprepitant reduces the impact of nausea on daily function during f... 2017
Details breast cancer (BC): longitudinal analyses from the phase III ExteNET trial... 2017
Details 449P Financial toxicity in patients with neuroendocrine tumors: Impact of a... 2017
Details 715P Jab1 silencing inhibits proliferation and sensitizes to cisplatin in b... 2017
Details 980P Factors Negatively Affecting Voluntary Cervical Cancer Screening Among... 2017
Details 1254P Tolerance and outcomes of stereotactic radiosurgery combined with ant... 2017
Details 1542PD Anticipative approach to improve safety: An innovative daily hospita... 2017
Details 178P Second interim analysis of HerSCin, a German non-interventional study ... 2017
Details 450P Pancreatic exocrine insufficiency (PEI) in patients (pts) with well- d... 2017
Details 716P The nationwide cancer genome screening project in Japan, SCRUM- Japan ... 2017
Details T cell spatial distribution and function in ovarian cancer... 2017
Details 1255P Dabrafenib and Trametinib combination in real life patients including... 2017
Details 1544PD Development of an online drug-drug interaction resource to support p... 2017
Details ) breast cancer (BrCa): Impact of neo-adjuvant (NAdj) versus adjuvant (Adj)... 2017
Details 451P Final analysis of time to subsequent disease progression/death in pati... 2017
Details 717P Prognostic implication of inflammation-based prognostic scores in pati... 2017
Details 982P Phase II study of the safety and efficacy of oral capecitabine in pati... 2017
Details T) in BRAF V600 Mutant Resectable Stage IIIB/C/D Melanoma (NeoTrio Trial)... 2017
Details 1545PD The effect of cannabis use on tumor response to nivolumab in patient... 2017
Details 180P Adjuvant endocrine treatment: Stop or continue?... 2017
Details 452P Temozolomide-capecitabine (TemCap) chemotherapy for neuroendocrine neo... 2017
Details 718P Phase 2 study of triplet chemotherapy with oxaliplatin, irinotecan and... 2017
Details 983P Investigation of the clinicopathological features of vulva cancer: a r... 2017
Details 1257TiP KEYNOTE 029: Phase 1/2 randomized study of pembrolizumab (pembro) p... 2017
Details 1546PD Impact of sarcopenia on dose limiting toxicities in metastatic color... 2017
Details 181P Use and effectiveness of adjuvant ovarian function suppression (OFS) i... 2017
Details 453P Efficacy of recombinant human endostatin combined with chemotherapy in... 2017
Details 719P Prognostic impact of hepatitis B virus (HBV) infection in advanced int... 2017
Details 984TiP Japan CHARLOTTE: Characterizing the cross-sectional approach to ovar... 2017
Details 1258TiP Phase 2 Study Comparing Pembrolizumab with Intermittent/short- term... 2017
Details 1547PD Phase 3 safety evaluation of an intravenous formulation of NEPA, a n... 2017
Details 182P A phase II randomised study of Adjuvant hypo-fractionated radiotherapy... 2017
Details 454P Comparison of clinical efficacy of SST analogues therapy (lanreotide a... 2017
Details 720P Inoperable carcinoma gallbladder: Comparison of two palliative chemoth... 2017
Details bevacizumab in stage III-IV ovarian, fallopian tube & peritoneal cancers (... 2017
Details 1260TiP Late physical, psychological and social consequences of ipilimumab ... 2017
Details 1548PD Quality of life (QOL) evaluation of patients in a phase 3 study comp... 2017
Details 183P Intrinsic tumor features underlying clinical subtype discordance in ea... 2017
Details 455P Metastatic neuroendocrine neoplasia (mNEN) treatments in over 70 years... 2017
Details 721P Surgical indication for advanced intrahepatic cholangiocarcinoma accor... 2017
Details 986TiP A randomized, double-blind, placebo-controlled multicenter phase 3 t... 2017
Details 1261P mRNA capture sequencing enabled liquid biopsy screening... 2017
Details 1549PD Multicenter randomized controlled trial to evaluate the efficacy of ... 2017
Details 184P Distribution of genomically defined recurrence risk in luminal A and B... 2017
Details 456P Modified staging classification for gastric neuroendocrine carcinomas ... 2017
Details 722P A phase 2 study of lenvatinib monotherapy as second-line treatment in ... 2017
Details 987TiP OReO/ENGOT Ov-38: A phase IIIb trial of olaparib maintenance retreat... 2017
Details 1262P Use of droplet digital PCR for quantitative and automatic analysis of... 2017
Details 1550P Primary prevention of nausea and vomiting induced by moderately emeto... 2017
Details 185P The first report of multicenter validation study of 95-gene classifier... 2017
Details 457P Predictive factors in GEP-NEN: The integrated role of Ki67, beta-caten... 2017
Details 723P Genotyping and mRNA profiling reveal actionable targets in biliary tra... 2017
Details 988TiP ARIEL4: An international, randomised phase 3 study of the PARP inhib... 2017
Details 1263P BRCA1 large gene rearrangements (LGRs) in Russian breast cancer patie... 2017
Details 1551P Risk factors of chemotherapy-induced nausea and vomiting during cispl... 2017
Details 186P Breast cancer PAM50 subtypes: Correlation between RNA-Seq and multiple... 2017
Details 458P The preoperative blood lymphocyte-to-monocyte ratio acts as a superior... 2017
Details 724P HER-2/HER-3 pathway as a potentially-actionable target in biliary trac... 2017
Details 989TiP OCTOVA: A randomised phase II trial of olaparib, chemotherapy, or ol... 2017
Details 1264P Clinical evaluation of low density array based EGFR mutation detectin... 2017
Details 1552P Evaluation of Antiemetic Practices for Prevention of Chemotherapy- in... 2017
Details 187P Summary of head-to-head comparisons of patient (pt) risk classificatio... 2017
Details 459P Follow-up and recurrence in resected gastroenteropancreatic neuroendoc... 2017
Details 725P Actionable molecular alterations in advanced biliary tract carcinomas:... 2017
Details 990TiP A multicentre phase II study of AZD1775 plus chemotherapy in patient... 2017
Details 1265P Correlation of somatic genomic alterations between tissue genomics an... 2017
Details 1553P A pooled analysis evaluating the combination antiemetic therapy on ch... 2017
Details 188P The impact of Oncotype DX breast cancer assay results on clinical prac... 2017
Details 460P Elevated levels of 5-HIAA and CgA in patients with PanNETs from the CL... 2017
Details 726P Precision medicine for patients with advanced biliary tract cancers: U... 2017
Details 992TiP N-DUR: Matched pair pharmacodynamics study of neoadjuvant durvalumab... 2017
Details 1266P Analytical and clinical validation of a next-generation sequencing- b... 2017
Details 1554P Efficacy of neurokinin-1 receptor antagonists in the prevention of Ch... 2017
Details , HER2- early breast cancer (EBC) following EndoPredict testing... 2017
Details 461P The prognostic value of cytokeratin 7, 19, thyroid transcription facto... 2017
Details 727P Preoperative chemoradiotherapy after induction FOLFIRINOX improve R0 r... 2017
Details 993TiP Comparing doses and fractionation regimens for high dose rate brachy... 2017
Details 1267P Combination of solid and liquid biopsy genomic profiling for tumor he... 2017
Details 1555P Pharmacokinetic (PK) study of a single oral dose of NEPA in Chinese h... 2017
Details 190P Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant ... 2017
Details paclitaxel in cancer patients with bone metastases... 2017
Details 728P Intratumoral heterogeneity of SMAD4 immunohistochemical (IHC) expressi... 2017
Details 994O Equivalent efficacy of a biosimilar rituximab and reference rituximab ... 2017
Details 1268P Retrospective analysis of a SHIVA01 trial cohort using functional mut... 2017
Details 1556P Iron deficiency anaemia in oncology: an epidemiological prospective s... 2017
Details 191P Pathological proliferation score to predict genomic risk categories in... 2017
Details 462P A nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to... 2017
Details 729P Outcome of patients with pancreatic adenocarcinoma with complete patho... 2017
Details 995O Interim results from a phase 1 first-in-human study of flotetuzumab, a... 2017
Details 1269P Integrative multi-platform meta-analysis of gene expression profiles ... 2017
Details 1557P Nutritional risk as a predictor of short-term outcomes in a prospecti... 2017
Details primary breast cancer (BC), using standard and TAILORx 21-gene recurrence ... 2017
Details 463P Plasma protein fingerprinting and machine learning for the diagnosis o... 2017
Details 730P Interim health related quality of life (QoL) from LAPACT, a Phase 2 tr... 2017
Details 996O Risk of developing acute myeloid leukemia (AML) in well- differentiate... 2017
Details 1270P 3D Cultured Tumour from Patients to Predict Treatment Response... 2017
Details 1558P A patient-centered approach to the re-development of supportive care ... 2017
Details 193P Oncotype DX score, menopausal status and body mass index... 2017
Details 464P CXCR4 inhibition by ulocuplumab prevents EMT of pNET cells in vitro... 2017
Details 731P Prognosis of familial pancreatic cancer (FPC): A matched case analysis... 2017
Details 997PD Split dosing of daratumumab (D) in a phase 1b study of D plus carfilz... 2017
Details 1271P 5-ALA administration for photodynamic diagnosis of peritoneal metasta... 2017
Details 1559P Multidimensional telemonitoring of cancer patients (pts) receiving ch... 2017
Details 194P Comparisons of tumor-infiltrating lymphocytes and 21-gene recurrence s... 2017
Details 466P Mixed adeno-neuroendocrine carcinoma (MANEC) of the gastroenteropancre... 2017
Details 732P Should pancreatic cancer be included in BRCA1/2 testing criteria?... 2017
Details 998PD Management of infusion-related reactions (IRRs) in patients (pts) rec... 2017
Details 1272P Diagnostic performance of dedicated breast PET scanner with a ring de... 2017
Details 1560P A pilot study to evaluate the feasibility, usability, and perceived s... 2017
Details 195P The 70-gene signature in node positive breast cancer: 10-year follow-u... 2017
Details 467P Incidence of adrenal gland tumor as a second primary malignancy: SEER ... 2017
Details 733P Sequential chemo-chemoradiation (CCRT) in locally advanced pancreas ca... 2017
Details 999PD Comparison of efficacy of new therapies between younger and older pat... 2017
Details 1273O Results of the phase III IFCT-0302 trial assessing minimal versus CT-... 2017
Details 1561P Study of the satisfaction level of an education program for cancer pa... 2017
Details / HER2-breast cancer... 2017
Details 468P Activity of temozolomide (TMZ) in patients (PTS) with malignant pheoch... 2017
Details 735P The prognostic significance of infiltrating lymphocytes in resectable ... 2017
Details 1000PD Copanlisib treatment in patients with relapsed or refractory indolen... 2017
Details 1274PD Analysis of immunoregulatory biomarkers in early stages of non- smal... 2017
Details 1562P Factors influencing the use of thromboprophylaxis in cancer outpatien... 2017
Details 197P Understanding BRCA1 and BRCA2 mutated breast cancer cases in Romania: ... 2017
Details 469P Neuroendocrine carcinoma of the uterine cervix: A retrospective monoce... 2017
Details 736P Randomized phase 2 trial of peri- or post-operative chemotherapy in re... 2017
Details 1001PD Tumor gene expression signatures of BCR/PI3K dependence in associati... 2017
Details 1275PD Stemness characterization of tumorspheres from non-small cell lung c... 2017
Details 1563P Literature review of TPOR agonists for CIT... 2017
Details 198P The prevalence of CD146 expression in breast cancer subtypes and its r... 2017
Details 470TiP AGITG NABNEC: A randomised phase II study of nab-paclitaxel in combi... 2017
Details 737P TP53 mutation predicts sensitivity to adjuvant gemcitabine in pancreat... 2017
Details 1002PD Standardized mortality ratios and event-free survival as new predict... 2017
Details 5cm), II, IIIA non-small cell lung cancer comparing S-1 versus S-1 with ci... 2017
Details 1564P Random optimization interactive system based on Kernel learning (RISK... 2017
Details 199P Neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios in breast c... 2017
Details 471TiP A multicentre, randomised, double-blind, parallel-group, placebo- co... 2017
Details capecitabine, cisplatin (PAXG regimen) in metastatic pancreatic adenocarcin... 2017
Details 1003PD A multicentre phase II trial addressing lenalidomide (LEN) maintenan... 2017
Details 1278PD Major pathological response after preoperative chemotherapy as a sur... 2017
Details 1565P Association between systemic inflammation and symptoms in advanced ca... 2017
Details 200P Vitamin D as a prognostic factor in triple negative early breast cance... 2017
Details 472TiP Phase 2 clinical investigation of BPM31510 (ubidecarenone) alone and... 2017
Details 740P The impact of UGT1A1 genetic polymorphism on safety in unresectable pa... 2017
Details 1004PD Follicular lymphoma: clinical and mollecular characteristics of hist... 2017
Details 1279P Factors predicting worse outcomes in patients with N0 lung adenocarci... 2017
Details 1566P Outcomes of patients with malignancy admitted to the intensive care u... 2017
Details 201P CDK12: New breast and ovarian cancer predisposition gene in Tatar popu... 2017
Details 473O Three versus six months adjuvant oxaliplatin-based chemotherapy for pa... 2017
Details 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alone... 2017
Details 1005PD Prognostic nomogram for overall survival in previously untreated pat... 2017
Details 1280P Regulatory variants in cancer-related pathway genes predict survival ... 2017
Details 1568P Management of thrombosis in cancer patients in Greece... 2017
Details 202P Prognostic value of master transcriptional regulators (MTRs) in early ... 2017
Details 474O Treatment outcome according to tumor RAS mutation status in TRICOLORE ... 2017
Details 743P Tumor hyaluronan (HA) is a novel biomarker: Results of the randomized ... 2017
Details 1006PD Does the omission of vincristine affect outcome and survival in pati... 2017
Details 1281P Relevance between PD-L1 and radiological invasiveness in pathologi- c... 2017
Details 1569P Incidence and outcome of Incidental Pulmonary Embolism (IPE) in oncol... 2017
Details 203P Survival outcomes of all patients treated with breast carcinosarcoma a... 2017
Details panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS ... 2017
Details 744P Overall survival and immunologic responses in metastatic pancreatic ad... 2017
Details 1007PD Preliminary results of novel safety interventions in adult patients ... 2017
Details 1282P Characterization of cancer stem cell and immune microenvironment inte... 2017
Details 1570P Immune related adverse events associated with ipilimumab and nivoluma... 2017
Details 204P ESR1, Ph-mTOR, CDK4/6 and PD-L1 expression as prognostic (and potentia... 2017
Details 476O Neoadjuvant FOLFOX 4 versus FOLFOX 4 plus cetuximab versus immediate s... 2017
Details 745P Circulating levels of ADAM12, a stromal activation biomarker, are pred... 2017
Details 1008PD ZUMA-4 preliminary results: phase 1 study of KTE-C19 chimeric antige... 2017
Details 1283P Non-invasive detection of lung cancer by identifying copy number aber... 2017
Details 1571P Febrile Neutropenia: a systematic review of the first 5 years of a ca... 2017
Details 205P The pregnancy and fertility (PREFER) study: A prospective cohort study... 2017
Details 478O Efficacy and safety of Sym004 in refractory metastatic colorectal canc... 2017
Details 746P COnsensus statement on mandatory measurements in PAncreatic cancer tri... 2017
Details 1009PD Treatment patterns in elderly patients (pts) with acute myeloid leuk... 2017
Details 1284P HOXA-related long non-coding RNAs impact prognosis in early stage NSC... 2017
Details 1572P G-CSF and G-CSF biosimilars: a meta-analysis of randomized clinical t... 2017
Details 206P Incidence of permanent alopecia following adjuvant chemotherapy in wom... 2017
Details 479O Consensus molecular subtypes (cms) as predictors of benefit from bevac... 2017
Details 747P Phase I study of resminostat/S-1 combination in patients with pre-trea... 2017
Details 1010P Event free survival at 24 months: A new endpoint in diffuse large B- ... 2017
Details 1285P Association between polymorphisms in microRNA target sites and surviv... 2017
Details 1573P Pharmacokinetic and pharmacodynamic comparability of B12019: A propos... 2017
Details 207P Significant changes in dietary intake and physical activity after brea... 2017
Details 480O Prognostic value of methylator phenotype in stage III colon cancer tre... 2017
Details 748P Comparisons of outcomes of patients with advanced pancreatic cancer (A... 2017
Details 1011P Interpreting progression-free survival and overall survival data in b... 2017
Details 1286TiP Neo-adjuvant chemo/immunotherapy for the treatment of resectable st... 2017
Details 1575P Impact of resistance exercise on metabolic syndrome (MetS) parameters... 2017
Details 208P Prevention of cardiotoxicity in breast cancer patients: A randomized p... 2017
Details 481PD Sidedness influences prognosis in stage III but not in stage II colon... 2017
Details 749P Musculoskeletal Events (MSEs) with PEGPH20 treatment and management in... 2017
Details 1012P Role of prephase treatment prior to definitive chemotherapy in diffus... 2017
Details 1287PD Preoperative chemotherapy and radiotherapy concomitant to cetuximab ... 2017
Details 1576P Body mass index (BMI), lifestyle behaviors, and perceptions in cancer... 2017
Details R ) in the preoperative treatment of women with primary breast cancer (ABC... 2017
Details 482PD Robot-assisted vs laparoscopic vs open abdominoperineal resections fo... 2017
Details 750P Phase Ib study of PF-04136309 (an oral CCR2 inhibitor) in combination ... 2017
Details 1013P The role of FDG-PET/CT in detecting bone marrow involvement in diffus... 2017
Details 1288PD Randomized phase ii trial comparing chemoradiotherapy with chemother... 2017
Details 1577P Barriers to improving awareness of the importance on exercise and die... 2017
Details 210P Dedicated breast PET for predicting residual disease after breast canc... 2017
Details 483PD Perioperative chemotherapy with or without cetuximab in patients (pts... 2017
Details 751P Metastatic pancreatic cancer: Real Life data from the german quality o... 2017
Details 1014P Evaluation of various prognostic scores and impact of cell of origin ... 2017
Details 1289PD Clinical course in patients with stage III non-small cell lung cance... 2017
Details 1578P Current perspectives of healthcare providers on weight loss and suppo... 2017
Details 212TiP IMpassion031: A phase III study comparing neoadjuvant atezolizumab (... 2017
Details ipilimumab (IPI): CheckMate 142... 2017
Details 752P FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer:... 2017
Details 1015P The prognostic impact of serum albumin and absolute neutrophil count ... 2017
Details 1290P DNA repair gene expression in bronchial washing fluid as new molecula... 2017
Details 1579P A survey of patient acceptance of skin toxicities from cetuximab- bas... 2017
Details 213TiP PIONEER- Pre-operative wIndOw study of letrozole plus PR agonist meg... 2017
Details 485PD Randomized phase III study of adjuvant chemotherapy with S-1 versus c... 2017
Details 753P Quality of life (QoL) of patients (pts) with metastatic pancreatic can... 2017
Details 1016P Autologous stem cell transplantation (ASCT) is safe and effective for... 2017
Details 1291P Diagnosis and monitoring of non-small cell ung cancer patients by nex... 2017
Details 1580P Increase in cetuximab-induced skin rash and hypomagnesemia in patient... 2017
Details 214TiP VENTANA (SOLTI-1501): Antiproliferative effect of the addition of or... 2017
Details 486O Sequential first-line therapy of metastatic colorectal cancer (mCRC) s... 2017
Details 754P Impact of the duration of diabetes mellitus (DM) on the outcomes of me... 2017
Details 1017P Phenotypic and functional characterization of tumor infiltrating lymp... 2017
Details pemetrexed (PEM) combined with thoracic radiotherapy (TRT) for locally adva... 2017
Details 1582P NeuroCog-FX study: A multicenter cohort study on cognitive dysfunctio... 2017
Details /HER2- early breast cancer... 2017
Details 487P International comparison of stage-specific treatment of and survival f... 2017
Details 755P Prognostic value of neutrophil-lymphocyte ratio in first line treatmen... 2017
Details 1018P International prognostic scores (IPS-7, IPS-3 and IPS-3 new) for pred... 2017
Details 1294P Real world data of practice patterns and outcomes for pemetrexed plus... 2017
Details 1583P Autonomic neuropathy in geriatric patients with gynecologic cancer re... 2017
Details 216TiP OlympiA: A randomized phase III trial of olaparib as adjuvant therap... 2017
Details 488P Early postoperative PET-CT in patients with pathological stage III col... 2017
Details 756P Treatment patterns, clinical characteristics, and outcomes of patients... 2017
Details ) and interleukin 13 (IL13) expression on clinical outcome in patients with... 2017
Details NSCLC (POPLAR and OAK)... 2017
Details 1586P Potential drug interactions in older patients with cancer: Updated da... 2017
Details 217O A gene signature of chemo-immunization to predict outcome in patients ... 2017
Details 489P Role of body composition in early stage colorectal cancer (CRC) outcom... 2017
Details 757P Safety and efficacy of gemcitabine/nabpaclitaxel in elderly patients w... 2017
Details 1020P Clinical impact of atypical phenotypes in adult t cell lymphoma/ leuk... 2017
Details NSCLC: Results from the randomized OAK study... 2017
Details 1587P How do Spanish medical oncologists manage breakthrough pain? A nation... 2017
Details 218P Prognostic estimates of Ki-67 percentage drop after neoadjuvant che- m... 2017
Details 490P North Japan multicenter phase II study of FOLFOX as adjuvant chemother... 2017
Details 758P Updated results of a phase II study of gemcitabine, erlotinib, and S-1... 2017
Details 1021P Evaluation of the PI3K pathway in peripheral t-cell lymphoma... 2017
Details 1297O Randomized results of fixed-duration (1-yr) vs continuous nivolumab i... 2017
Details 1588P Enhanced supportive care in early phase clinical trials... 2017
Details 219P Immune function and response to neoadjuvant chemotherapy in hormone re... 2017
Details 491P Factors predicting adherence to a tailored-dose adjuvant treatment bas... 2017
Details 759P PANOVA: a phase II study of TTFields (150 kHz) with concomitant standa... 2017
Details 1022P Safety and tolerability of chemotherapy (CT) containing high doses of... 2017
Details 1300PD Impact of co-occurring genomic alterations on overall survival of BR... 2017
Details 1589P Cancer patient interest and perceptions of lifestyle behavior program... 2017
Details 220P Safe resection margins in breast-conserving surgery... 2017
Details 492P Benefits of upfront primary tumour resection (UPTR) according to sided... 2017
Details 760P Risk factors for febrile neutropenia (FN) in unresectable/recurrent pa... 2017
Details 1023P Evaluation of safety, tolerability and efficacy of temsirolimus in pa... 2017
Details 1301PD Three-year follow-up from CheckMate 017/057: Nivolumab versus doceta... 2017
Details 1590P The investigate relationship between severe neutropenia and ABCB1and ... 2017
Details 221P A clinically applicable model to predict risk of relapse in patients t... 2017
Details 493P Surgical quality and the impact of liver resection on outcome in the n... 2017
Details 761P A Phase I study of LDE225 in combination with gemcitabine and nab- pac... 2017
Details 1024P Clinical impact of FISH analysis in extramedullary plasmacytomas... 2017
Details 1302PD IFCT-1502 CLINIVO: Real-life experience with nivolumab in 600 patien... 2017
Details 1591P Hepatitis B and C reactivation rates due to cytotoxic chemotherapy in... 2017
Details 222P Role of radiotherapy and its impact on survival of male breast cancer:... 2017
Details 494P Short-term clinical outcome from a randomized controlled trial of the ... 2017
Details 762P Impact of advances in systemic chemotherapy for unresectable pancreati... 2017
Details 1025P Independent predictors of one year mortality in patients with primary... 2017
Details 70 years and with poor performance status... 2017
Details 1592P Meta-analysis of individual patient safety data from six randomized, ... 2017
Details 223P Early characteristics of breast neoplasms on contrast-enhanced ultra- ... 2017
Details 495P Prognostic impact of tumor deposits in colorectal cancer with lymph no... 2017
Details 763P Randomized phase 2 study of PEGPH20 Plus nab-paclitaxel/ gemcitabine (... 2017
Details 1026P Endoscopic evaluation of acute intestinal GVHD after allogeneic hemat... 2017
Details 1304PD Correlation of radiation pneumonitis history before nivolumab and on... 2017
Details 1593P The preventive role of intravenous L-alanyl L-glutamine in reducing t... 2017
Details 224P Synchronous and metachronous breast cancer in Ukraine... 2017
Details 496P Predictive potential of tumour-stroma ratio on benefit from adjuvant b... 2017
Details 764P Crucial relationship of neural wiskott aldrich syndrome protein(N- WAS... 2017
Details 1027P Surveillance stool culture and its association with febrile neutropen... 2017
Details 1305PD Whole body PD-1 and PD-L1 PET in pts with NSCLC... 2017
Details 1594P Biosimilar epoetin alfa (HX575) for the treatment of chemotherapy- in... 2017
Details 225P Clinical outcomes of single versus double hormone receptor positive br... 2017
Details 497P Tumor-stroma interactions and response to targeted agents in preclinic... 2017
Details 765P The nationwide cancer genome screening project in Japan SCRUM- Japan G... 2017
Details 1028P L-arginine targeted for the anthracycline cardiotoxicity prevention ... 2017
Details 1306PD Hyperprogressive disease (HPD) is frequent in non-small cell lung ca... 2017
Details 1595P Experience with the implant of vascular access devices by medical onc... 2017
Details 226P The correlation between toll-like receptor genes polymorphisms, tumor ... 2017
Details 498P Molecular profiling of colorectal tumors stratified by the histologica... 2017
Details 766P Frequent ERBB3 (HER3) activating mutations in small bowel adenocarcino... 2017
Details 1029P Multiple myeloma complicated by concomitant cardiac pathology... 2017
Details 1307PD Detection of driver and resistance mutations in leptomeningeal metas... 2017
Details 1596P Management of chemotherapy-related side effects- do patients know whe... 2017
Details 227P Triple negative breast cancer: 10-year survival update of the applied ... 2017
Details 499P The characteristics and prognostic factors in colorectal cancer contai... 2017
Details systemic chemotherapy vesus systemic chemotherapy alone for patients with ... 2017
Details 1030P Evaluation of dose intensification of cytarabine in postremission the... 2017
Details 1308PD Preliminary efficacy and safety of lorlatinib in patients (Pts) with... 2017
Details 1597P The effects of nurses empathy skills on attitudes towards patients wi... 2017
Details 228P A decade of HER2-targeted therapy in older patients with invasive brea... 2017
Details 500P Effect of lateral lymph node dissection for lower rectal cancer: An ad... 2017
Details 768TiP A prospective multicenter, phase II trial (NAC-GA trial) to evaluate... 2017
Details 1031P The EUROSKI biomarker study: Analyzing the mechanisms of treatment-fr... 2017
Details 1309P Efficacy and safety of necitumumab and pembrolizumab combination ther... 2017
Details 1598P Can postponement of death be used in shared decision making in patien... 2017
Details 229P Dedicated breast PET to predict pathological complete response after n... 2017
Details 502P Effects of mesorectal fascia (MRF) status for locally advanced rectal ... 2017
Details 769TiP Randomized phase II study of modified FOLFIRINOX versus gemcitabine ... 2017
Details 1032P Pharmacodynamic and pharmacokinetic evaluation of SY-1425 (tamibarote... 2017
Details 1310P Survival and safety of atezolizumab by best overall response (BOR) in... 2017
Details 1599P Cancer patient attitudes and preferences towards smoking status asses... 2017
Details 230P Efficacy and safety profile of the adriamycin/cyclophosphamide (AC) fo... 2017
Details 503P Planned organ preservation for selected T2, T3 rectal cancer: French e... 2017
Details 770TiP NIFE-trial: Liposomal irinotecan (nal-IRI) plus 5-fluorouracil (5-FU... 2017
Details B-Cell acute lymphoblastic leukemia (ALL)... 2017
Details 1311P LKB1 loss is a novel genomic predictor of de novo resistance to PD-1/... 2017
Details 1600P Optimizing Physician Surveys in Pharmacovigilance Using ecancer Onlin... 2017
Details 232P Pregnancy associated breast cancer spotlights... 2017
Details 504P Comparison between magnetic resonance imaging (MRI) and pathology in t... 2017
Details 771TiP A feasibility study of TAS-118 plus oxaliplatin as perioperative che... 2017
Details 1034TiP Phase III randomized, double-blind, controlled studies of the PI3K ... 2017
Details 1312P Prediction of survival with durvalumab in locally advanced or metasta... 2017
Details 1601P Ideal cardiovascular health (ICVH) in patients with a recent diagnosi... 2017
Details chemo as neoadjuvant followed by pembro vs placebo as adjuvant therapy for... 2017
Details 505P FOLFIRINOX as induction treatment in rectal cancer patients with synch... 2017
Details 772TiP A phase 1/2 study of ramucirumab plus nivolumab in patients with pre... 2017
Details 1035TiP A multicenter, randomized, phase 3 study of pomalidomide and dexame... 2017
Details 1313P Immune-related adverse events (irAEs) in advanced NSCLC patients trea... 2017
Details 1602P Additive effect of vinca alkaloids as the risk factor for hearing imp... 2017
Details chemo for previously untreated, locally recurrent, inoperable or metastatic... 2017
Details 506P Neoadjuvant treatment with mFOLFOXIRI alone versus chemoradiotherapy i... 2017
Details 773TiP PRODIGE 51 - GASTFOX: Phase III randomised trial evaluating FOLFOX w... 2017
Details cyclophosphamide, bortezomib and dexamethasone (Dara-CyBorD) in previously... 2017
Details 1314P Association between immune-related adverse events (irAEs) and atezoli... 2017
Details 1603P Development and validation of chewing swallowing inventory (CSI) in h... 2017
Details /-endocrine therapy), or non-small-cell lung cancer (NSCLC)... 2017
Details 507P Updated survival results of FACT trial: Multicenter phase II trial of ... 2017
Details 775TiP KEYNOTE-240: Phase 3, randomized study of pembrolizumab (pembro) vs ... 2017
Details 1037TiP A double blind randomized phase 2 PILOT study of ERYASPASE in patie... 2017
Details 1315P Efficacy and safety data from patients with advanced non-squamous NSC... 2017
Details 1604P The Relationship between Oral Supportive Care and Oral Complications ... 2017
Details / HER2- advanced breast cancer... 2017
Details radiation therapy with/ without bevacizumab as preoperative treatment for ... 2017
Details 776TiP PACTO: A single center, randomized, phase II study of the combinatio... 2017
Details 1039TiP Phase 2a study of a novel stapled peptide ALRN-6924 disrupting MDMX... 2017
Details 1316P Efficacy and immune activation with PEGylated human IL-10 (AM0010) in... 2017
Details 1605P Safety and effectiveness of sensor-controlled scalp cooling in women ... 2017
Details 237O A phase II trial of pan-HER inhibitor Poziotinib, in patients with HER... 2017
Details 509P Immunological features of resected tumor after neoadjuvant chemotherap... 2017
Details 777TiP ATTRACTION-04 (ONO-4538-37): A randomized, multicenter, phase 2/ 3 s... 2017
Details dexamethasone in a phase 2 open-label, single-arm, multicenter trial in pat... 2017
Details line treatment and quality of life (QoL) in advanced refractory non-small ... 2017
Details 1606P Pharmacokinetics and safety of FOLFOX therapy in patients undergoing ... 2017
Details 238PD A randomized, double-blind study of PF-05280014 (a potential trastuzu... 2017
Details 510P The ADC value of post-RT might predict TRG after neoadjuvant radiother... 2017
Details 778TiP ATTRACTION-05 (ONO-4538-38/BMS CA209844): a randomized, multicenter,... 2017
Details 1042O Durvalumab for recurrent/metastatic (R/M) head and neck squamous cell... 2017
Details 1318P Italian nivolumab expanded access programme in non-squamous non-small... 2017
Details 1608TiP Heath related quality of life (HRQOL) assessment for patients with ... 2017
Details 239PD A phase II trial of dasatinib (D) in combination with trastuzumab (T)... 2017
Details 511P Polyethylene glycol embolics loaded with irinotecan for chemoembolizat... 2017
Details 779TiP Adjuvant oxaliplatin plus S-1 (SOX) with concurrent radiotherapy ver... 2017
Details 1043O Treatment beyond progression with nivolumab in patients with recurren... 2017
Details 1319P Efficiency of nivolumab in the treatment of second-line advanced non-... 2017
Details 1609TiP Impact of a cancer care coordination program based on health inform... 2017
Details 240PD Comprehensive genomic profiling of primary and metastatic CDH1 mutate... 2017
Details 512P Neoadjuvant systemic chemotherapy prior to cytoreductive surgery and h... 2017
Details 780TiP Impact of early palliative care on overall survival of patients with... 2017
Details 1044O Long-Term Safety and Clinical Outcomes of Atezolizumab in Head and Ne... 2017
Details 1320P Use of nivolumab in elderly patients with advanced non-squamous NSCLC... 2017
Details 1610TiP Oncological Home-Hospitalization: Prospective randomized trial to e... 2017
Details ve advanced or metastatic breast cancer, and in a PIK3CA mutant sub- popula... 2017
Details 513P Efficacy and tolerability of chronomodulated FOLFIRINOX (chronoIFLO) a... 2017
Details 781TiP Apatinib and irinotecan combination treatment in first-line chemothe... 2017
Details 1045PD Adjuvant androgen deprivation therapy for high-risk androgen recepto... 2017
Details 1322P Real life experience with nivolumab in patients (pts) with advanced n... 2017
Details 1611TiP A novel multimodal treatment strategy for cancer cachexia; rational... 2017
Details 242PD Initial results of a phase 1 dose expansion cohort of M6620 (formerly... 2017
Details 514P A multicentre, randomized phase 3 study on the optimization of the com... 2017
Details 782TiP PANOVA-3: A phase 3 study of TTFields with gemcitabine and nab- pacl... 2017
Details 1046PD Overexpression of the c-MET proto-oncogene in salivary duct carcinom... 2017
Details 1323P Baseline corticosteroids (CS) could be associated with absence of ben... 2017
Details 1612TiP Multicenter prospective cohort study to evaluate of eye disorder in... 2017
Details 243PD OlympiAD: Further efficacy outcomes in patients with HER2-negative me... 2017
Details 515P First-in-human Phase I study of bacterial RNA interference therapeutic... 2017
Details 1733PD New promising combination therapy of a mitochondrial metabolism inhi... 2017
Details 1047PD Mammary analogue secretory carcinoma (MASC): clinical characteristic... 2017
Details 1324P Practical effectiveness efficacy and safety of nivolumab for advanced... 2017
Details 1613TiP Outpatient monitoring with an eTool: self managed or with pro activ... 2017
Details ) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup an... 2017
Details 516P A Multicentre Phase I/II Study of TAS-102 with nintedanib in patients ... 2017
Details 1734PD Anti-CTGF human recombinant monoclonal antibody pamrevlumab increase... 2017
Details 1048PD RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or M... 2017
Details 1325P Generalization and representativeness of phase III immune checkpoint ... 2017
Details 1614TiP A Phase I safety study of topical Calcitriol (BPM 31543) for the pr... 2017
Details , HER2 ABC... 2017
Details 517P BEACON CRC: safety lead-in (SLI) for the combination of binimetinib (B... 2017
Details P) When Added to Androgen Deprivation Therapy (ADT) in LATITUDE on Patient ... 2017
Details 1049PD Relationship between PD-L1 expression and survival in head and neck ... 2017
Details 1326P Long-term follow-up results of stage III-IV non-small-cell lung cance... 2017
Details 1615O Pembrolizumab as second or further line treatment in relapsed maligna... 2017
Details 246PD Efficacy of two times four versus continuous eight cycles of paclitax... 2017
Details 518P Sequential therapy with bevacizumab and epidermal growth factor recept... 2017
Details 784O Docetaxel (D) with androgen suppression (AS) for high-risk localized p... 2017
Details 1050PD The ELAN-ONCOVAL (ELderly heAd and Neck cancer-Oncology eValuation) ... 2017
Details 1327P The Lung Immune Prognostic Index (LIPI), a predictive score for immun... 2017
Details 1616O Multicenter, nonrandomized, open-label Phase 1b study of FP-1039/ GSK... 2017
Details 247P A single-arm, phase ii study assessing the efficacy of pembrolizumab (... 2017
Details 519P Outcomes in patients receiving maintenance therapy in two panitumumab ... 2017
Details 785O Lutetium-177 PSMA (LuPSMA) theranostics phase II trial: Efficacy, safe... 2017
Details 1051PD A phase 1, multicenter, open-label, dose-escalation, combination stu... 2017
Details 1328P Association of single nucleotide polymorphisms with efficacy in nivol... 2017
Details 1617PD Multiplexed targeted proteomics signature for serum diagnostic of ma... 2017
Details /HER2) first-line advanced breast cancer (ABC): A PALOMA-2 subgroup analysi... 2017
Details Aflibercept in patients with metastatic colorectal cancer... 2017
Details 786PD DNA repair gene panel mutations in young onset and aggressive vs non ... 2017
Details 1052PD First-line paclitaxel plus carboplatin with/without bevacizumab in r... 2017
Details 1329P Systematic inflammation and histologic grade in non-small cell lung c... 2017
Details PEM/CIS in chemo-na ve patients (pts) with malignant pleural mesothelioma ... 2017
Details /HER2- metastatic breast cancer (MBC) after chemotherapy for advanced disea... 2017
Details 521P Multicenter phase II study of biweekly XELIRI plus bevacizumab as a se... 2017
Details 787PD Prognostic associations of prostate-specific antigen (PSA) decline wi... 2017
Details 1053PD Refining staging system for nasopharyngeal carcinoma treated with in... 2017
Details 1330P Impact of next generation TKI and co-occurring mutations in ALK- posi... 2017
Details 1619PD Malignant pleural mesothelioma immune microenvironment and checkpoin... 2017
Details 250P A global phase III clinical study comparing NK105 and paclitaxel in me... 2017
Details 523P Mechanism of pelareorep (Pel)-mediated cell death in a Phase I study i... 2017
Details /- endocrine therapy versus endocrine therapy alone for PSA failure after r... 2017
Details 1054PD A New Classification for Nasopharyngeal Carcinoma... 2017
Details 1331P Detection of EGFR T790M in Asia-Pacific patients (pts) with EGFR muta... 2017
Details 1620P Outcomes of malignant pleural mesothelioma (MPM) patients (p) treated... 2017
Details 251P Efficacy and safety of olaparib combined with eribulin in patients wit... 2017
Details 524P Bevacizumab first line and impact on subsequent anti-EGFR activity... 2017
Details prednisolone (P) for metastatic castration-resistant prostate cancer (mCRP... 2017
Details 1055P Nivolumab vs investigators choice (IC) in patients with recurrent or ... 2017
Details 1332P Influence of plasma T790M mutation on clinical decision after 1st gen... 2017
Details 1621P Baseline hyperglycemia was predictive of poor outcome in pleural mali... 2017
Details 252P Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2- p... 2017
Details 525P Efficacy of anti-EGFR antibodies combined with chemotherapy for elderl... 2017
Details 790PD Safety and immunogenicity of a DNA-vaccine immunotherapy in men with ... 2017
Details 1056P Estimated costs of treatment-related adverse events (TRAEs) for recur... 2017
Details 1333P Detectability of RET fusions by amplicon-based next generation sequen... 2017
Details 1622P Evaluation of quality of life in survivors with malignant pleural mes... 2017
Details /HER2- endocrine therapy na ve (EN) advanced breast cancer - an exploratory... 2017
Details 75) with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorecta... 2017
Details 791PD Re-education of tumor-associated macrophages by CXCR2 blockade drives... 2017
Details 1057P Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), ... 2017
Details 1334P A comparison of Bronchial Washing Fluid (BWF) and histologic samples ... 2017
Details 1623P Staging and assessment of the response to PET-CT treatment in non- sm... 2017
Details , HER2 ABC... 2017
Details 527P Toxicity and efficacy of flat-dosed versus body-surface area (BSA)- do... 2017
Details inhibitor, in combination with enzalutamide in male subjects with metastat... 2017
Details 1058P Does hyper-progression exist among head and neck cancer patients trea... 2017
Details 1335P EGFR T790M detection in TKI-na ve NSCLCs carrying sensitive EGFR muta... 2017
Details 1624P Liquid Withdarw technique prominently reduced the incidence of pneumo... 2017
Details 255P Phase 1 dose-escalation study of single-agent ZW25, a HER2-targeted bi... 2017
Details 528P Efficacy of panitumumab and cetuximab in patients with chemotherapy-re... 2017
Details 793PD Phase 1 study of the PSMA-targeted small-molecule drug conjugate EC11... 2017
Details 1059P PD-L1 Detection and Assay Performance in Squamous Cell Carcinoma of t... 2017
Details 1336P ALK fusion variants detection by targeted RNA-next generation sequenc... 2017
Details 1625P Phase II trial of S-1 treatment as palliative-intent chemotherapy for... 2017
Details ) metastatic breast cancer (MBC) pretreated with everolimus: Real-life data... 2017
Details 529P Multicenter randomized phase II trial (BEVATOMOX) assessing the raltit... 2017
Details 794P EPI-506 (ralaniten acetate), a novel androgen receptor (AR) N-terminal... 2017
Details 1060P Programmed death ligand-1overexpression is a poor prognostic factor f... 2017
Details 1337P A meta-analysis on epidemiology of ROS1 rearrangement in Asian and no... 2017
Details 1626P Detects esophageal squamous cell carcinoma via liquid biopsy of circu... 2017
Details -isoform selective PI3K inhibitor, in Japanese patients with advanced solid... 2017
Details 530P Safety analysis of phase Ib study of FOLFOXIRI plus ramucirumab as fir... 2017
Details 796P Phase I expansion cohort of TAS-115, a novel oral MET/VEGFR/FMS inhibi... 2017
Details 1061P The prognostic role of PD-L1 expression in tumor and immune cells in ... 2017
Details 1338P EGFR mutation detection in plasma cell-free DNA correlates with clini... 2017
Details 1627TiP ONCOS-102 and pemetrexed/cisplatin in patients with unresectable ma... 2017
Details -catenin translocation in advanced solid tumors... 2017
Details 531P Prognostic factors and specific populations in the pharmacogenetic ran... 2017
Details 797P Phase II trial of SM88 in non-metastatic biochemical recurrent prostat... 2017
Details 1062P Immune profile analysis of head and neck squamous cell carcinoma befo... 2017
Details 1339P A large prospective cohort study of the clinical features of advanced... 2017
Details 1628O Development of the Manchester Cancer Research Centre Molecular Tumour... 2017
Details 259P Adherence to International ESO-ESMO (ABC) guide-lines in HER2-ve metas... 2017
Details 532P Analysis of efficacy and prognostic factors in second-line chemotherap... 2017
Details 798P Impact of the addition of metformin (Met) to abiraterone (Abi) in meta... 2017
Details 1063P Phenotyping of the immune infiltrate in oropharyngeal squamous cell c... 2017
Details 1340P Transcriptomic analysis of bronchoalveolar lavage cells from advanced... 2017
Details 1629O A systematic rapid autopsy program tracks temporal and spatial hetero... 2017
Details 260P M-bioscore: A practical tool for predicting outcomes among patients wi... 2017
Details 533P A large retrospective multicenter study evaluating prognosis and chemo... 2017
Details 799P Steroid switch: Reversal of resistance to abirateron acetate (AA) and ... 2017
Details 1064P High-dose versus low-dose cisplatin with definitive concurrent radiot... 2017
Details 1341P Assessing response to immunotherapy in patients with non-small cell l... 2017
Details 1630PD Association of programmed cell death 1 ligand (PD-L1) expression wit... 2017
Details , HER2 MBC? A systematic literature review... 2017
Details 534P Exploratory analysis of baseline microsatellite instability (MSI) stat... 2017
Details 801P Effect of sequence on outcome of prostate cancer patients: retrospecti... 2017
Details 1065P 3-weekly or weekly cisplatin concurrently with radiotherapy for patie... 2017
Details 1342P Detection of epidermal growth factor receptor mutations in circulatin... 2017
Details 1631PD Prominent immune suppressive tumor microenvironment in female never-... 2017
Details , HER2 MBC... 2017
Details 535P Investigation of MSI status in acquired resistance to 5-fluorouracil t... 2017
Details 802P Patient preference between Cabazitaxel and Docetaxel for first-line ch... 2017
Details 1066P Hyperfractionated twice daily re-irradiation (bid re-RT) and chemothe... 2017
Details non-small cell lung cancer (NSCLC) previously treated with 2nd-generation ... 2017
Details 1632PD A novel radiomic based imaging tool to monitor tumor lymphocyte infi... 2017
Details 263P Survival gains from advances in first-line systemic therapy for HER2- ... 2017
Details 536P Docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy in the tre... 2017
Details 803P Indirect comparison of abiraterone acetate and docetaxel for treatment... 2017
Details 1067P Raltitrexed versus 5-fluorouracil with cisplatin and concurrent radio... 2017
Details 1344P Brigatinib (BRG) in anaplastic lymphoma kinase (ALK)-positive non- sm... 2017
Details 1633PD Co-amplification of KIT/KDR/PDGRA in over 100,000 advanced cancer ca... 2017
Details metastatic breast cancer (MBC) patients (pts) with (w) or without (w/o) bra... 2017
Details 537P P2 study of ADXS11-001 Immunotherapy in patients with persistent/ recu... 2017
Details 804P Practice patterns in metastatic castration-resistant prostate cancer (... 2017
Details platinum-based therapy (PBT) for first-line (1L) treatment of patients wit... 2017
Details 1345P Intracranial efficacy of brigatinib (BRG) in patients (Pts) With criz... 2017
Details 1634P FGFR pathway genomic aberrations and response to FGFRs inhibitors... 2017
Details /HER2- metastatic breast cancer treated with a first-line endocrine therapy... 2017
Details 538P Relationship between pretreatment levels of circulating DNA, circulati... 2017
Details 805P Efficacy and safety of first-line combined androgen blockade in advanc... 2017
Details 1069P Primary surgery versus chemoradiotherapy for advanced oropharyngeal a... 2017
Details 1347P Treatment beyond disease progression: ALK inhibitors in ALK- rearrang... 2017
Details resistance: Establishing a translational research framework in FGFR-altere... 2017
Details 266P Use of everolimus in advanced hormone receptor positive metastatic bre... 2017
Details 539P Circulating tumor cells (CTCs), molecular alterations and their correl... 2017
Details Docetaxel (D) or ADT alone for metastatic hormone sensitive prostate cance... 2017
Details 1070P Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisp... 2017
Details 1348P Overall survival (OS) in patients (pts) with EGFR T790M-positive adva... 2017
Details 1636P EPHA2 receptor is involved in in vivo acquired resistance to anti- Ep... 2017
Details 267P Can contemporary trials in HER2-negative metastatic breast cancer (mBC... 2017
Details 540P Analysis of liquid biopsies from metastatic colorectal carcinoma (mCRC... 2017
Details 807P First interim results of the radium-223 (Ra-223) REASSURE observationa... 2017
Details 1071P Postoperative radiotherapy with weekly cisplatin in locally advanced ... 2017
Details ) NSCLC in LUX-Lung (LL) 3, 6 and 7... 2017
Details cetuximab in RAS WT metastatic colorectal cancer (mCRC) patients (pts) in ... 2017
Details 268P What are the treatment patterns and overall survival (OS) in patients ... 2017
Details 541P Circulating cell-free DNA as predictor of treatment failure after neoa... 2017
Details 65 years with hormone-naive systemic prostate cancer (HNSPCa)... 2017
Details 1072P Effectiveness and toxicities of cetuximab in combination with concurr... 2017
Details 1350P Phase I study of TAS-121, a novel third-generation epidermal growth f... 2017
Details 1638P Clinical value of cfDNA and CTCs in EGFR mutations detected in advanc... 2017
Details 269P Outcomes of systemic therapy for advanced triple-negative breast cance... 2017
Details panitumumab... 2017
Details 809P Cabazitaxel plus prednisone and prophylaxis of neutropenia complicatio... 2017
Details 1073P Safety and efficacy of nimotuzumab with concurrent chemoradiotherapy ... 2017
Details 1351P The addition of apatinib to gefitinib or icotinib for advanced non- s... 2017
Details 1639P Tucatinib, a HER2 selective kinase inhibitor, is active in patient de... 2017
Details 1O Wild-type KRAS mediates growth inhibition and resistance to MEK inhibito... 2017
Details 270P Untreated hormone receptor positive/HER2-negative metastatic breast ca... 2017
Details 543P Dynamic changes in levels of gene mutations using circulating tumor DN... 2017
Details 810P Assessment of health-related quality of life (HRQL) in PROSELICA: A Ph... 2017
Details 1074P A phase II study of combination chemotherapy with cetuximab/S-1/ low ... 2017
Details 1352P Leptomeningeal carcinomatosis from EGFR-mutated non-small cell lung c... 2017
Details 1640P PI3K/RICTOR-mTORC2 axis as a driver of prognosis and potential drugga... 2017
Details 2O CDCP1 initiates tumorigenesis and cooperates with PTEN loss to promote s... 2017
Details 271P Can we predict subsequent brain metastasis in patients with metastatic... 2017
Details 544P The frequency of RAS mutation in circulating tumor DNA predicts worse ... 2017
Details 811P Cabazitaxel followed by androgen deprivation therapy (ADT) significant... 2017
Details 1075P Role of induction chemotherapy in locally advanced T4b oral cavity ca... 2017
Details 1353P CNS response to osimertinib in Asian-Pacific patients (pts) with T790... 2017
Details 1641P Combination of duligotuzumab, anti HER3 antibody or taselisib, Pi3k i... 2017
Details 3PD New targets in triple negative breast cancer: Role of oncostatin M rece... 2017
Details 272P Pathological characteristics and prognosis of a cohort of 57 patients ... 2017
Details 545P Ep idermal growth factor rece p tor ( E GFR) co p y number (CN) as a b... 2017
Details 812P Health-related quality of life (HRQL) in patients (pts) with metastati... 2017
Details 1076P Concurrent chemoradiotherapy (CCRT) versus induction docetaxel, cispl... 2017
Details 1354P Osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive a... 2017
Details 1642P The TLR9 agonist lefitolimod modulates tumor microenvironment and imp... 2017
Details 4PD GGNBP2 suppresses tumor growth and cancer stem cell load of triple nega... 2017
Details 273P External validation of modified breast graded prognostic assessment fo... 2017
Details 546P Survival analysis of KR A S, NR A S, BR A F, P I K3C A wild ty p e (w... 2017
Details 813P Real-world use of docetaxel for metastatic castration-resistant prosta... 2017
Details 1077P Do patients over 70 years with advanced head and neck squamous cell c... 2017
Details ) advanced non-small cell lung cancer (NSCLC): findings from a global named... 2017
Details 1643P Circulating immune-profile as predictor of outcome in advanced NSCLC ... 2017
Details 5PD The acquired resistance to the combination of the anti-EGFR cetuximab a... 2017
Details metastatic breast cancer (MBC) from the SystHERs registry... 2017
Details 547P ULT R A clinical trial: Pros p ective com p arative clinical outcome ... 2017
Details androgen deprivation therapy (ADT)... 2017
Details 1078P Multidisciplinary team management in head and neck cancer: The real l... 2017
Details 1356P Octogenarians with EGFR-mutated non-small cell lung Cancer (NSCLC) tr... 2017
Details 1644P Monitoring the effect of cytostatic treatment by immune activity... 2017
Details 6PD FPA150, a novel B7-H4 therapeutic antibody with checkpoint blockade and... 2017
Details metastatic breast cancer (MBC) in the SystHERs registry... 2017
Details 548P Prognostic im p act of BR A F and KR A S mutations according to the co... 2017
Details 815P Prognostic value of systemic inflammatory biomarkers in patients with ... 2017
Details 1079P Long-term response to second-line afatinib in patients with recurrent... 2017
Details 1357P Prospective evaluation of the relationship between erlotinib concentr... 2017
Details gene expression signatures (GES) and tumor-infiltrating immune cells (IC) ... 2017
Details 7P GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the bre... 2017
Details 276P Defining priorities for research: Interim results of the Canadian meta... 2017
Details 549P Gene ex p ression signatures in BR A F V600 E mutant colorectal cance... 2017
Details 816P 68Ga-PSMA-PET/CT as a changing practice tool in biochemically recurren... 2017
Details 1081P Benefit of cetuximab addition to a platinum-fluorouracil-based chemot... 2017
Details 1358P First-in-human phase I study of PF-06747775, a third-generation mutan... 2017
Details 1646P Clinical factors associated with mutation burden in non-small cell lu... 2017
Details 9P Kynurenine-3-monooxygenase (KMO) protein promotes triple negative breast... 2017
Details 277P Real-world treatment patterns and outcomes among elderly metastatic tr... 2017
Details 550P Prognostic significance of BR A F mutation - associated gene signature... 2017
Details 817P Prostascore: A simplified tool for predicting outcomes among patients ... 2017
Details 1082P A pilot study of apatinib in heavily pretreated metastatic adenocarci... 2017
Details pts: Results of the NOWEL network... 2017
Details 1646P Integrative analysis of NSCLC identifies tumor genetic profiles assoc... 2017
Details 10P PIM1 kinase promotes cell migration via SHP2 in triple-negative breast ... 2017
Details 278P Effect of neoadjuvant chemotherapy on disease free survival and over a... 2017
Details 552P Mutational status and metastatic p atteRn in a cohort Of A Dvanced c... 2017
Details 818P PSA doubling time (PSADT) and proximal PSA predict metastasis-free sur... 2017
Details 1083P Natural history and prognostic factors of head and neck cancer patien... 2017
Details 1360P Phase II trial of AZD9291 in second line treatment after acquired res... 2017
Details 1648P B7-H3 (CD276) on circulating epithelial tumor cells (CETCs) correlate... 2017
Details 11P SHP-1 agonist SC-43 enhanced the anti-tumor effect of docetaxel through... 2017
Details ight Canadian prospective observational study 2nd subgroup analysis... 2017
Details 553P First - line p anitumumab (P) p lus ca p ecitabine (C) for the treat... 2017
Details 819P PSA kinetics impact on CT-PET PSMA uptake in prostate cancer... 2017
Details 1084P Prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) on over... 2017
Details 1362P Safety and clinical activity of DS-6051b, a ROS1/NTRK inhibitor, in J... 2017
Details 1649P Survival of non-small cell lung cancer patients predicted from expres... 2017
Details breast cancer cells... 2017
Details 45 years old. A large observational multicenter cohort survival analysis... 2017
Details 554P Prevalence of KR A S/NR A S/BR A F mutations detected by massive p ara... 2017
Details 820P Combining functional imaging with circulating biomarker analysis to im... 2017
Details 1085P Association of ERP29 genetic polymorphism in microRNA-binding site wi... 2017
Details 1363P Efficacy and safety of abemaciclib combined with either LY3023414 or ... 2017
Details 1650P YKL-39 induces monocytes migration and angiogenesis and inversely cor... 2017
Details 13P AXL as a potential primary and secondary trastuzumab resistance mechani... 2017
Details 281P Cell-free circulating DNA as independent prognostic markers in metasta... 2017
Details 555P A nalysis of angiogenesis biomarkers for ramucirumab (R A M) efficacy ... 2017
Details 821P A polymorphism in the promoter of the FRAS1 gene is associated with me... 2017
Details 1086P Diagnostic and prognostic impact of plasma osteopontin in nasopharyng... 2017
Details 1364P Final clinical results from SUNRISE: A phase III, randomized, double-... 2017
Details 1651P Pre-treatment neutrophil lymphocyte ratio/platelet lymphocyte ratio a... 2017
Details breast cancer cell line model... 2017
Details 282P Gene alteration in triple negative breast cancer patients in a phase I... 2017
Details 556P A novel C p G p anel is inde p endently associated with colorectal c... 2017
Details 822P Phenotypic circulating tumor cell (CTC) classifier of genomic instabil... 2017

1 2 3 Next